Bleichroeder LP Cue Biopharma, Inc. Call Options Transaction History
Bleichroeder LP
- $323 Million
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CUE
# of Institutions
57Shares Held
11.9MCall Options Held
22KPut Options Held
1.2K-
Vanguard Group Inc Valley Forge, PA2.06MShares$1.62 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$597,8210.0% of portfolio
-
Geode Capital Management, LLC Boston, MA631KShares$498,7110.0% of portfolio
-
Robertson Stephens Wealth Management, LLC San Francisco, CA479KShares$378,0150.02% of portfolio
-
Sigma Planning Corp Ann Arbor, MI447KShares$353,2680.01% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $28M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...